Skip to content

CVCT CardioBrief

  • Home
  • About
    • Mission
  • CVCT Forum
  • Cardiobrief Archive
  • FAQ
    • Contact
    • Privacy Policy
    • Cookies Policy
    • Terms of use
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
search
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
search

Login / Signup

May 26, 20212021-05-26T06:58:17-04:00

Speculations on PARADISE-MI (sacubitril/valsartan post-MI) before the full results

By : Alexandra Nowbar

Marc Pfeffer presented the results of PARADISE-MI at ACC last week. As discussed previously on CVCTCardiobrief, sacubitril/valsartan did not reduce the primary outcome compared to…

High Rate of Crossovers in ADAPTABLE Aspirin Dosing Trial
May 17, 20212021-05-17T11:22:46-04:00

High Rate of Crossovers in ADAPTABLE Aspirin Dosing Trial

By : Gregg Fonarow

Until now the optimal dosing of aspirin in terms of efficacy and safety for secondary prevention of atherosclerotic cardiovascular disease had not been previously well…

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 296 other subscribers

  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
 

Loading Comments...
 

You must be logged in to post a comment.